JellyBlue Official Website › Disclaimer
DisclaimerJellyBlue Disclaimer: What This Website Can and Cannot Tell You
JellyBlue is a dietary supplement. Its statements have not been evaluated by the FDA, and it is not intended to diagnose, treat, cure or prevent any disease.
The research on this website is about its ingredients, not about this gummy; the ratings are the distributor’s figures; the prices are dated; and the lot and certificate reference name a production run, not a laboratory result.
By the JellyBlue Team at Gojellyblue · Medical review: Dr. Helen Bernie, DO, MPH · Revised
The JellyBlue FDA statement
The federal wording, then six plain limits on everything else here.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. JellyBlue is a dietary supplement, not a drug, and the FDA does not approve supplements before they are sold.
A supplement, not a drug
A chewable gummy, not a capsule and not liquid drops. One gummy is one serving; the bottle holds thirty.
Research on ingredients
Every study cited tested an ingredient, usually at a different dose and in a specific extract. None tested this gummy.
Results vary
What one buyer reports is not a prediction for another. Food, sleep and activity still matter.
Ratings are supplied
The 4.3 score, the 789 reports and the 9,520 orders are the distributor’s summary figures.
Prices are dated
Read off the seller’s order page on 21 September 2026. The checkout shows the current figure.
Codes are references
Lot JEL-26/GO-5083 and certificate reference JEL-5083-26-GO are filing references, not laboratory proof.
JellyBlue and your health
The label’s caution, quoted once, and the one interaction worth naming.
JellyBlue is for healthy adults 18 and over. The label’s own caution reads, in full:
Do not exceed recommended dose. The caution names pregnant or nursing mothers, children under the age of 18 and individuals with a known medical condition, and tells them to consult a physician before using this or any dietary supplement. Keep out of reach of children. Leave the bottle unused if its safety seal is damaged or missing.The JellyBlue label
The interaction to know about
Of the seven actives, ashwagandha has the clearest interaction record. NCCIH notes that it might interact with medicines for diabetes and high blood pressure, immunosuppressants, sedatives, anti-seizure medicines and thyroid hormone, and that it should be avoided in pregnancy and while breastfeeding. Anyone taking one of those medicines should talk to their doctor before starting.
When to stop
Stop taking it if anything unexpected happens. LiverTox records rare cases of liver injury linked to ashwagandha supplements; signs such as yellowing skin or dark urine need prompt medical attention.
A change in energy or sexual function that worries you can have medical causes that no supplement addresses, and a daily gummy is not the tool for finding them.
The three JellyBlue front-label phrases, read plainly
What each phrase under the three front-panel icons does and does not say.
Male vitality support
A general wellness phrase for men. It names no condition, and nothing on this website turns it into a treatment claim.
Maximum strength
The label’s own description of its formula. It is not a comparison with any other product and not a measured potency.
Daily energy support
A phrase about everyday wellbeing. The label lists no caffeine or other stimulant among the actives or the other ingredients.
These three phrases are the ceiling for every claim on this website. Where a study measured something more specific, it is described as that study’s finding about an ingredient, never as something this gummy does.
JellyBlue amounts beside the research doses
Each of the seven printed amounts beside the dose its own research used.
| Active | On this panel | In the published research |
|---|---|---|
| Tongkat Ali extract | 200 mg | 100 mg or 200 mg a day of a standardised aqueous root extract for twelve weeks, in 105 men aged 50 to 70. The one amount on this panel that matches a trial dose. |
| Maca root extract | 100 mg | 1,500 mg or 3,000 mg a day for twelve weeks in the desire trial |
| Ashwagandha extract | 100 mg | clearest sleep effects at 600 mg a day and above, over eight weeks or longer |
| Horny goat weed extract | 100 mg | no human dose to compare; the published work is a laboratory study of its flavonoids |
| L-Arginine HCl | 50 mg | 1,500 to 5,000 mg a day across the ten trials in the meta-analysis |
| Beet root extract | 50 mg | 200 to 800 mg of nitrate a day, from beetroot juice, in eleven trials of 349 people |
| Grape seed extract | 50 mg | nineteen controlled trials; diastolic pressure fell 2.20 mmHg on average, and the size of the effect varied with dose and with duration |
The left column is this label. The right column is what a published study gave, read from its abstract. Tongkat ali at 200 mg is the one row that matches a trial dose, in a trial of a standardised water extract; the label does not say which extract it uses. The other rows sit below their trial doses, and horny goat weed has only laboratory work.
How to read a study cited on the JellyBlue website
Six questions to ask of any study before letting it speak for a product.
Its own extract
Trials test named preparations. The tongkat ali trial used a standardised water extract; a label may name only the plant.
Its own dose
Most trial doses are several times the amounts on this panel. The dose beside each finding is printed for that reason.
Its own people
Trials enrol particular groups, such as men aged 50 to 70 or adults with insomnia. A finding in one group may not carry to another.
Its own length
Most of the trials ran eight to twelve weeks. A result at week twelve says little about week one.
Its own funding
Some trials are paid for by the maker of the extract they test; the 2021 tongkat ali trial declares exactly that.
Its abstract
Figures on this website are read from each record’s abstract. The full paper can add detail the abstract leaves out.
The seller badges shown with JellyBlue
Four marks that are easy to read as more than they are.
Registered facility
A statement about the plant. It is not approval of the gummy.
Doctor formulated
A seller badge, not a mark on the label. No clinician is named anywhere on the label.
GMP
Good Manufacturing Practice. The badge names no certifying body.
Natural ingredients
The actives are plant and amino-acid extracts; the gummy base is sugar and pectin.
Our relationship to JellyBlue
Who runs this website, and how it is paid.
A retailer
Gojellyblue is a USA authorized JellyBlue retailer. It is not the manufacturer.
Paid on sales
This desk is paid when an order is placed through the order links on this website. That is why the links carry a sponsored label.
Independent in what it prints
The label sets the ceiling for every claim here, and the gaps are printed alongside the strengths.
Links and changes on the JellyBlue website
External links go to PubMed, the National Institutes of Health, MedlinePlus, the FTC and the Electronic Code of Federal Regulations. They are cited for what they say, and this desk does not control them.
This disclaimer is reviewed with the rest of the site. The current version is dated September 30, 2026. Questions go to the website inbox listed in the site footer.
Who should see a doctor before taking JellyBlue
JellyBlue is a dietary supplement for adults 18 and over. It is not a treatment for erectile dysfunction, low testosterone or any illness, and it is never a reason to stop or change a prescribed medicine.
Nitrate or PDE5 medicine users
Nitrates such as nitroglycerin are never combined with erection medicines like sildenafil, because the two together can cause a dangerous fall in blood pressure. L-arginine, beet root and grape seed act on that same nitric-oxide pathway, so the prescriber should see the JellyBlue panel before you start.
Blood pressure and blood thinners
Two actives, beet-root nitrate and grape seed, lowered blood pressure in published trials, and two botanicals have been linked to platelet effects. If you are treated for high blood pressure or take a blood thinner, ask a pharmacist first.
Heart conditions
With heart disease, chest pain on effort, a past heart attack, or advice to limit exertion, get a doctor’s clearance before using a product sold for male vitality.
Erection problems that are new
New or worsening erection trouble can come before a diagnosis of heart disease, diabetes or a hormone problem, as NIDDK and MedlinePlus describe. It is worth an appointment before any supplement.
Liver, thyroid and diabetes
Ashwagandha has a rare association with liver injury and can change thyroid hormone levels (NCCIH). Liver or thyroid disease, diabetes medicine and any other prescription are reasons to ask first.
If something feels wrong
Stop and call your doctor. Serious reactions can be reported to the FDA through MedWatch, and the FDA’s list of tainted sexual enhancement products is a reason to buy only where a lot number can be traced.
A change in erections, drive or energy is a medical question before it is a product question: book a doctor first, and mention any heart, blood-pressure, nitrate or diabetes medicine you take.
JellyBlue disclaimer: frequently asked questions
Short answers on approval, prescriptions, authorship and payment.
Is JellyBlue approved by the FDA?
No dietary supplement is approved by the FDA before it is sold. The blue roundel among the seller’s web badges reads REGISTERED FACILITY, a statement about the plant where the gummies are made. It is not printed on the label.
Can JellyBlue replace a prescribed medicine?
No. It is a dietary supplement, not a drug. Do not stop or change a prescribed medicine in order to take it; raise it with the prescriber first.
Why does the JellyBlue website print gaps as well as strengths?
Because a buyer deciding on a supplement needs both. The dose table above sets each printed amount beside the dose its research used, so you can judge the distance for yourself before you order.
Who writes the JellyBlue pages?
The JellyBlue Team at Gojellyblue, an editorial desk. No named medical expert is claimed; every figure can be checked against the label or a cited source instead.
Does this website earn money from JellyBlue orders?
Yes. This desk is paid when an order is placed through its order links, which carry a sponsored label for that reason.
Are the JellyBlue buyer ratings independent?
No. The score, the star split and the order count are the distributor’s summary figures for this desk. They are printed on the page with that note and kept out of its structured data.
Why are the JellyBlue prices dated?
Because prices change. Each one on this website was read off the seller’s order page on 21 September 2026, and the checkout shows the current figure.
Sources for the JellyBlue disclaimer
The federal pages and the trial cited above, plus NCCIH on using supplements wisely.
- Chinnappan SM, George A, Pandey P, et al, Effect of Eurycoma longifolia standardised aqueous root extract-Physta on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study, Food Nutr Res, 2021;65:5647, (PubMed record 34262417) https://pubmed.ncbi.nlm.nih.gov/34262417/
- Ashwagandha, National Center for Complementary and Integrative Health, National Institutes of Health, https://www.nccih.nih.gov/health/ashwagandha
- Ashwagandha, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda MD, https://www.ncbi.nlm.nih.gov/books/NBK548536/
- Health Products Compliance Guidance, Federal Trade Commission, Bureau of Consumer Protection, December 2022, https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance
- Using Dietary Supplements Wisely, National Center for Complementary and Integrative Health, National Institutes of Health, https://www.nccih.nih.gov/health/using-dietary-supplements-wisely
